Cortef and Myeloma recurrence - a phase IV clinical study of FDA data

Summary:

Myeloma recurrence is reported as a side effect among people who take Cortef (hydrocortisone), especially for people who are female, 50-59 old, also take Nitroglycerin, and have Hypercalcaemia of malignancy.

The phase IV clinical study analyzes which people have Myeloma recurrence when taking Cortef. It is created by eHealthMe based on reports of 4,132 people who have side effects when taking Cortef from the FDA, and is updated regularly.

What is Cortef?

Cortef has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 4,254 Cortef users. Check the latest studies of Cortef.

What is Myeloma recurrence?

Myeloma recurrence (recurrence of cancer of the plasma cells - a kind of white blood cell) is found to be associated with 176 drugs and 54 conditions by eHealthMe. Check the latest studies of Myeloma recurrence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

4,132 people reported to have side effects when taking Cortef.
Among them, 15 people (0.36%) have Myeloma recurrence.

Among these 15 people:

What is the gender of people who have Myeloma recurrence when taking Cortef? *

female: 100 %
male: 0.0 %

What is the age of people who have Myeloma recurrence when taking Cortef? *

What are other drugs people take besides Cortef? *

What are other side effects people have besides Myeloma recurrence? *

X-Ray Abnormal: 15 people, 100.00%
Hypokalemia (low potassium): 15 people, 100.00%
Extremity Necrosis (death of body tissue of arms and legs): 15 people, 100.00%
Facial Pain: 15 people, 100.00%
Hearing Loss: 15 people, 100.00%
Heart Disease: 15 people, 100.00%
Hip Fracture: 15 people, 100.00%
Hyperkalemia (damage to or disease of the kidney): 15 people, 100.00%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 15 people, 100.00%
Hypotension (abnormally low blood pressure): 15 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 100.00%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 15 people, 100.00%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 11 people, 73.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cortef and have Myeloma recurrence?

- Check whether Myeloma recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cortef:

Cortef (4,254 reports)

Browse all side effects of Cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myeloma recurrence:

Myeloma recurrence (176 drugs)

Browse all the conditions that are associated with Myeloma recurrence:

Myeloma recurrence (54 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone (the active ingredients of Cortef) and Cortef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.